Jefferies Financial Group Inc. Buys Shares of 163,817 Cencora, Inc. $COR

Jefferies Financial Group Inc. purchased a new position in Cencora, Inc. (NYSE:COR) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 163,817 shares of the company’s stock, valued at approximately $46,357,000.

Several other hedge funds and other institutional investors have also modified their holdings of COR. Kemnay Advisory Services Inc. acquired a new stake in shares of Cencora during the 4th quarter worth approximately $25,000. Elyxium Wealth LLC bought a new position in Cencora during the 4th quarter worth $27,000. Elevation Wealth Partners LLC increased its position in Cencora by 506.2% in the second quarter. Elevation Wealth Partners LLC now owns 97 shares of the company’s stock worth $27,000 after buying an additional 81 shares during the period. Archer Investment Corp lifted its stake in Cencora by 134.3% in the fourth quarter. Archer Investment Corp now owns 82 shares of the company’s stock valued at $28,000 after buying an additional 47 shares during the last quarter. Finally, Bell Investment Advisors Inc bought a new stake in Cencora in the second quarter valued at $28,000. 97.52% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Cencora

In other news, EVP Elizabeth S. Campbell sold 11,300 shares of the firm’s stock in a transaction dated Monday, August 24th. The shares were sold at an average price of $324.12, for a total transaction of $3,662,556.00. Following the completion of the transaction, the executive vice president owned 19,455 shares in the company, valued at approximately $6,305,754.60. This trade represents a 36.74% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Lauren M. Tyler acquired 550 shares of the stock in a transaction dated Monday, June 22nd. The stock was acquired at an average cost of $270.23 per share, for a total transaction of $148,626.50. Following the purchase, the director directly owned 4,359 shares in the company, valued at approximately $1,177,932.57. The trade was a 14.44% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. 0.38% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

Several research firms have recently commented on COR. UBS Group upped their price target on shares of Cencora from $412.00 to $430.00 and gave the stock a “buy” rating in a research report on Thursday, August 6th. Bank of America upped their target price on shares of Cencora from $280.00 to $285.00 and gave the stock a “neutral” rating in a research report on Wednesday, June 24th. Morgan Stanley raised their price target on shares of Cencora from $342.00 to $346.00 and gave the company an “overweight” rating in a research note on Friday, August 7th. Wells Fargo & Company boosted their price objective on Cencora from $331.00 to $395.00 and gave the stock an “overweight” rating in a research report on Tuesday, August 11th. Finally, Wall Street Zen raised Cencora from a “hold” rating to a “buy” rating in a report on Saturday, August 8th. Thirteen equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $370.85.

Cencora Stock Down 2.0%

Shares of COR stock opened at $321.31 on Friday. Cencora, Inc. has a 1 year low of $244.82 and a 1 year high of $377.54. The stock has a market cap of $61.32 billion, a PE ratio of 23.87, a price-to-earnings-growth ratio of 1.88 and a beta of 0.57. The business’s fifty day moving average is $306.37 and its 200-day moving average is $310.80. The company has a debt-to-equity ratio of 3.53, a quick ratio of 0.58 and a current ratio of 0.93.

Cencora (NYSE:COR) last announced its quarterly earnings data on Wednesday, August 5th. The company reported $4.48 earnings per share for the quarter, beating the consensus estimate of $4.35 by $0.13. Cencora had a return on equity of 125.45% and a net margin of 0.79%.The business had revenue of $84.75 billion during the quarter, compared to analyst estimates of $84.31 billion. During the same quarter in the prior year, the firm posted $4.00 earnings per share. The company’s revenue was up 5.1% on a year-over-year basis. Equities analysts expect that Cencora, Inc. will post 17.87 earnings per share for the current fiscal year.

Cencora declared that its board has initiated a stock buyback plan on Thursday, May 21st that authorizes the company to repurchase $2.00 billion in outstanding shares. This repurchase authorization authorizes the company to reacquire up to 3.9% of its shares through open market purchases. Shares repurchase plans are usually a sign that the company’s board believes its shares are undervalued.

Cencora Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, August 31st. Shareholders of record on Friday, August 14th will be issued a $0.60 dividend. This represents a $2.40 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date of this dividend is Friday, August 14th. Cencora’s dividend payout ratio is presently 17.83%.

About Cencora

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.